LB
BIIB icon

Leo Brokerage’s Biogen BIIB Stock Holding History

Leo Brokerage’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$2.51M Sell
8,801
-2,589
-23% -$771K 0.29% 55
2023
Q1 		$3.17M Buy
+11,390
New +$3.15M 0.47% 39
2022
Q2 		– Sell
-11,501
Closed -$2.42M – 191
2022
Q1 		$2.42M Buy
+11,501
New +$2.5M 0.39% 51

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Leo Brokerage's BIIB Position: Q2 2023 in Review

Leo Brokerage reduced its Biogen (BIIB) stake by 23% in Q2 2023, selling an estimated $771K and leaving 8,801 shares worth $2.51M. The position accounts for 0.29% of the portfolio, ranked #55.

Leo Brokerage first reported a position in BIIB in Q1 2022 and has held it in 3 quarters since. The position peaked at $3.17M in Q1 2023. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • Leo Brokerage held 8,801 shares of Biogen worth $2.51M as of Q2 2023.
  • Leo Brokerage sold 2,589 Biogen shares in Q2 2023, an estimated $771K.
  • Biogen made up 0.29% of Leo Brokerage's portfolio in Q2 2023, its #55 holding.
  • Leo Brokerage first reported a position in Biogen in Q1 2022 and has held it in 3 quarters since.
  • Leo Brokerage's Biogen position peaked at $3.17M in Q1 2023.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Leo Brokerage's 13F filing for Q2 2023, filed 25 Jul 2023.